Cathie Wood’s ARK Invest Sells Nearly 850,000 Shares of Takeda Pharma
One of Cathie Wood's Ark Invest funds sold nearly 850,000 shares of Takeda Pharmaceutical on December 7.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold nearly 850,000 shares of Takeda Pharmaceutical Co. Ltd. (NYSE: TAK | TAK Price Prediction) on Tuesday, as the share price of this fund traded was up 7% in the day’s session. Its share price is still negative over the past year.
[in-text-ad]
ARK Genomic Revolution ETF (NYSEARCA: ARKG) sold 846,189 shares of Takeda. At Tuesday’s closing price, this would have valued this sale at roughly $11.7 million. This is only a small fraction of the total holdings. This fund is down 32% over the past 52 weeks.
[nativounit]
Here is a quick look at all the trades that took place across all ARK ETFs:
| Fund | Direction | Ticker | Name | Shares |
|---|---|---|---|---|
| ARKF | Buy | DSYSJ | DISCOVERY | 55,621 |
| ARKG | Buy | SGFY | SIGNIFY HEALTH | 160,234 |
| ARKG | Sell | TAK | TAKEDA PHARMACEUTICAL | 846,189 |
| ARKK | Buy | SGFY | SIGNIFY HEALTH | 313,766 |
| ARKK | Buy | TDOC | TELADOC HEALTH | 63,567 |
| ARKK | Sell | EDIT | EDITAS MEDICINE | 138,796 |
| ARKQ | Buy | BLDE | BLADE AIR MOBILITY | 11,926 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
[recirclink id=1008967][wallst_email_signup]
Contact [email protected] for any questions or corrections.





